supported by the National Natural Science Foundation of China (21210003 and 81230076 to H.J., 81773634 to M.Z. and 81430084 to K.C.);the “Personalized Medicines-Molecular Signature-based Drug Discovery and Development”, Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12050201 to M.Z.);National Key Research & Development Plan (2016YFC1201003 to M.Z.);the National Basic Research Program (2015CB910304 to X.L.)
Thanks to the fast improvement of the computing power and the rapid development of the computational chemistry and biology,the computer-aided drug design techniques have been successfully applied in almost every stage...
supported by the National Basic Research Program of China (973 Program;Grant No.2014CB964900);the National Natural Science Foundation of China (Grant Nos.21432002,21372022,and 21210003)
Recently an article published in Molecular Cell reveals the mechanism of a nuclear N6-methyladenosine(m^6A)reader,the YTH domain-containing protein 1(YTHDC1),in regulating pre-m RNA splicing[1].Meanwhile,two addit...
supported the National High Technology Research and Development Programme of China(2012AA020301,2012AA01A305);the Chinese Academy of Sciences(KSZD-EWL09-4);the National Natural Science Foundation of China(81230076,21210003)
In recent decades, high-performance computing(HPC) technologies and supercomputers in China have significantly advanced, resulting in remarkable achievements. Computational drug discovery and design,which is based on ...
supported by the grant from the National Natural Science Foundation of China (No. 21210003)
RNA methylation modifications have been found for decades of years, which occur at different RNA types of numerous species, and their distribution is species-specific. However, people rarely know their biological func...